Collegium Pharmaceutical, Inc. Common Stock COLL
Key Stats
- Today's Range
- $33.00 – $33.62
- 50-Day Range
- $31.54 – $40.50
- 52-Week Range
- $26.16 – $50.79
- Volume
- 490K shs
- Average Volume
- 422K shs
- Market Cap
- $1.09 billion
- P/E Ratio
- 16.48
- Dividend Yield
- —
Valuation
- P/E Ratio
- 16.48
- Price / Book
- 3.49
- Price / Sales
- 1.37
Short Interest
- Short Interest
- 11.38%
- Days to Cover
- 10.78
Financials (TTM)
- Revenue
- $796.33 million
- Net Income
- $74.95 million
- Net Margin
- 9.41%
- Return on Equity
- 23.99%
- Debt-to-Equity
- —
About Collegium Pharmaceutical, Inc. Common Stock
Collegium Pharmaceutical Inc is a diversified biopharmaceutical company committed to improving the lives of people living with serious medical conditions. The company has developed, licensed, and acquired a portfolio of meaningfully differentiated products for the treatment of attention deficit hyperactivity disorder (ADHD) and moderate to severe pain. It commercializes its products in the United States, including Jornay PM, Belbuca, Xtampza ER, Nucynta ER, Nucynta IR (collectively, the Nucynta Products), and Symproic. The company's product portfolio includes Jornay PM, Belbuca, Xtampza ER, Nucynta IR, Nucynta ER, and Symproic.
Related Stocks
Price and fundamental data are delayed and provided for informational purposes only. Not investment advice. See our disclaimer.